Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Marshmallow root (Althaea officinalis) is rich in high-molecular-weight mucilaginous polysaccharides that form protective gel barriers on mucosal surfaces, inhibit hyaluronidase-1 enzyme activity (IC₅₀ 7.7 mg/mL), and suppress pro-inflammatory cytokines including IL-6, with user surveys reporting significant relief of irritative cough and high tolerability (PMID 30064132). Its bioactive polysaccharides, flavonoids, and coumarins also support gut barrier integrity relevant to leaky gut (PMID 37110316), while comprehensive phytochemical reviews confirm antioxidant, immunomodulatory, and wound-healing properties attributable to uronic acid–rich polysaccharide fractions (PMID 37245776).
Reported Benefits (Provisional)
Origin & History
Marshmallow Root (Althaea officinalis) is a demulcent perennial herb indigenous to Europe, North Africa, and Western Asia. Flourishing in damp, marshy environments, its root is highly valued in traditional medicine for its soothing mucilage, providing significant functional benefits for gastrointestinal, respiratory, and skin health.
Research Narrative (Provisional)
A 2018 survey-based study published in Complementary Medicine Research found that marshmallow root extract significantly relieved irritative dry cough with excellent tolerability across two independent user cohorts (PMID 30064132; Fink C, 2018). A 2023 in vitro study in Microorganisms demonstrated that marshmallow root influenced beneficial culture bacteria growth and gut barrier markers relevant to leaky gut syndrome (PMID 37110316; Aleman RS, 2023). A comprehensive 2023 review in International Journal of Biological Macromolecules systematically detailed the isolation, structural characterization, and bioactivities—including antioxidant, anti-inflammatory, and immunomodulatory effects—of Althaea officinalis polysaccharides (PMID 37245776; Xue T, 2023). Toxicological safety assessments published in Toxics (2022) and Scientific Reports (2024) confirmed that commercially available marshmallow root products in Polish pharmacies met safety thresholds for heavy metal contaminants including lead, cadmium, and chromium (PMID 35448449; PMID 38438482; Jurowski K).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Macronutrients: Mucilage polysaccharides, Pectin - Minerals: Calcium, Magnesium, Zinc - Phytochemicals: Flavonoids, Tannins, Coumarins
Reported Mechanism (Provisional)
Marshmallow root's mucilage consists of high-molecular-weight galacturonorhamnans, arabinans, and glucans that hydrate and form viscous bioadhesive gel layers on epithelial and mucosal surfaces, physically shielding irritated tissues in the gastrointestinal tract, respiratory tract, and urinary system from further damage. These polysaccharides inhibit hyaluronidase-1 (HYAL-1)—a key enzyme in extracellular matrix degradation—with a reported IC₅₀ of 7.7 mg/mL, thereby preserving tissue integrity and reducing inflammation-driven hyaluronic acid breakdown (PMID 37245776). The root's flavonoid constituents (including kaempferol, quercetin glycosides, and hypolaetin-8-glucoside) and scopoletin-type coumarins downregulate NF-κB-mediated transcription of pro-inflammatory cytokines such as TNF-α and IL-6, while simultaneously scavenging reactive oxygen species through phenolic hydroxyl group electron donation. Additionally, the polysaccharide fractions stimulate macrophage phagocytosis and promote fibroblast proliferation via upregulation of growth factors, contributing to wound healing and immune modulation.
Clinical Narrative (Provisional)
Current evidence derives primarily from in vitro and cell-based studies rather than human clinical trials. Laboratory studies demonstrate that 100 μg/mL root extract reduces hydrogen peroxide-induced ROS production by 52.4% in macrophages and suppresses TNF-α release in lipopolysaccharide-stimulated immune cells. Anti-glycation studies show moderate 62.7-66.8% inhibition of advanced glycation end products in BSA-GLU assays. Human clinical trial data remains limited, representing a significant gap in therapeutic validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.